- Home
- OPOF vs PDSB Comparison
OPOF vs PDSB Comparison
Compare OPOF & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPOF
- PDSB
- Stock Information
- Founded
- OPOF 1922
- PDSB 2005
- Country
- OPOF United States
- PDSB United States
- Employees
- OPOF N/A
- PDSB N/A
- Industry
- OPOF Major Banks
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- OPOF Finance
- PDSB Health Care
- Exchange
- OPOF Nasdaq
- PDSB Nasdaq
- Market Cap
- OPOF 103.7M
- PDSB 114.9M
- IPO Year
- OPOF N/A
- PDSB N/A
- Fundamental
- Price
- OPOF $21.32
- PDSB $2.09
- Analyst Decision
- OPOF
- PDSB Strong Buy
- Analyst Count
- OPOF 0
- PDSB 3
- Target Price
- OPOF N/A
- PDSB $15.00
- AVG Volume (30 Days)
- OPOF 20.3K
- PDSB 562.9K
- Earning Date
- OPOF 10-24-2024
- PDSB 11-14-2024
- Dividend Yield
- OPOF 2.59%
- PDSB N/A
- EPS Growth
- OPOF N/A
- PDSB N/A
- EPS
- OPOF 1.60
- PDSB N/A
- Revenue
- OPOF $59,503,000.00
- PDSB N/A
- Revenue This Year
- OPOF N/A
- PDSB N/A
- Revenue Next Year
- OPOF N/A
- PDSB N/A
- P/E Ratio
- OPOF $12.95
- PDSB N/A
- Revenue Growth
- OPOF N/A
- PDSB N/A
- 52 Week Low
- OPOF $13.49
- PDSB $1.53
- 52 Week High
- OPOF $21.89
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- OPOF 63.59
- PDSB 28.76
- Support Level
- OPOF $20.30
- PDSB $1.90
- Resistance Level
- OPOF $21.89
- PDSB $2.12
- Average True Range (ATR)
- OPOF 0.66
- PDSB 0.23
- MACD
- OPOF -0.03
- PDSB -0.09
- Stochastic Oscillator
- OPOF 51.10
- PDSB 29.87
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.